Price-file publication check · 45 CFR § 180
F · 55
This hospital's published file contains little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
26,127
Insurances with rates
42
CPT / HCPCS codes
13,601
Most expensive procedures (gross)
405811353
$41,943
sipuleucel-T 250 mL IV Susp
Gross
$102,300
405811353
$41,943
sipuleucel-T 250 mL IV Susp
Gross
$102,300
405810920
$38,739
pegloticase 8 mg/mL Inj
Gross
$94,485
405810920
$38,739
pegloticase 8 mg/mL Inj
Gross
$94,485
405810763
$26,674
ocrelizumab 300 mg/10 mL Inj Soln
Gross
$65,058
405810763
$26,674
ocrelizumab 300 mg/10 mL Inj Soln
Gross
$65,058
405811243
$23,736
polatuzumab vedotin 140 mg Inj
Gross
$57,893
405811243
$23,736
polatuzumab vedotin 140 mg Inj
Gross
$57,893
405811442
$19,709
guselkumab 200 mg/20 mL IV Inj
Gross
$48,070
405811442
$19,709
guselkumab 200 mg/20 mL IV Inj
Gross
$48,070
405810353
$16,594
leuprolide 45 mg/6 months Inj
Gross
$40,474
405810353
$16,594
leuprolide 45 mg/6 months Inj
Gross
$40,474
405810645
$15,083
icatibant 30 mg/3 mL syringe
Gross
$36,787
405810645
$15,083
icatibant 30 mg/3 mL syringe
Gross
$36,787
405811298
$14,170
ublituximab-xiiy 150 mg/6 mL Inj
Gross
$34,560
405811298
$14,170
ublituximab-xiiy 150 mg/6 mL Inj
Gross
$34,560
405811316
$13,268
risankizumab-rzaa 600 mg/10 mL IV Soln
Gross
$32,360
405811316
$13,268
risankizumab-rzaa 600 mg/10 mL IV Soln
Gross
$32,360
405810690
$12,032
lanreotide 120 mg/0.5 mL Subcut Soln syringe
Gross
$29,346
405810690
$12,032
lanreotide 120 mg/0.5 mL Subcut Soln syringe
Gross
$29,346
405803773
$11,907
alteplase 100 mg/100 mL (EMERGENT OVERRIDE PE and MI ONLY) IV Inj
Gross
$29,042
405810960
$11,907
alteplase 100 mg/100 mL (continuous for MI) IV Inj
Gross
$29,042
405803773
$11,907
alteplase 100 mg/100 mL (EMERGENT OVERRIDE PE and MI ONLY) IV Inj
Gross
$29,042
405810960
$11,907
alteplase 100 mg/100 mL (continuous for MI) IV Inj
Gross
$29,042
405810415
$11,726
vedolizumab 300 mg IV Inj
Gross
$28,600
405810415
$11,726
vedolizumab 300 mg IV Inj
Gross
$28,600
405809439
$11,107
natalizumab 300 mg/15 mL IV Inj
Gross
$27,091
405809439
$11,107
natalizumab 300 mg/15 mL IV Inj
Gross
$27,091
405807552
$11,063
leuprolide 30 mg/4 months Inj
Gross
$26,983
405807552
$11,063
leuprolide 30 mg/4 months Inj
Gross
$26,983
405507171
$10,382
IR Fem/Pop Stent + Ather PTAIR FEM/POP STENT + ATHER PTA
Gross
$25,321
405507175
$10,382
IR Tib/Per Stent + Ather PTAIR TIB/PER STENT PTA + ATHER PTA
Gross
$25,321
405507171
$10,382
IR Fem/Pop Stent + Ather PTAIR FEM/POP STENT + ATHER PTA
Gross
$25,321
405507175
$10,382
IR Tib/Per Stent + Ather PTAIR TIB/PER STENT PTA + ATHER PTA
Gross
$25,321
405811275
$10,282
tenecteplase 50 mg/10 mL Inj
Gross
$25,079
405811275
$10,282
tenecteplase 50 mg/10 mL Inj
Gross
$25,079
405811361
$8,838
ravulizumab-cwvz 300 mg/3 mL Inj
Gross
$21,556
405811361
$8,838
ravulizumab-cwvz 300 mg/3 mL Inj
Gross
$21,556
405810930
$8,826
eculizumab 300 mg/30 mL IV Soln
Gross
$21,526
405810930
$8,826
eculizumab 300 mg/30 mL IV Soln
Gross
$21,526
405810649
$8,684
pegfilgrastim 6 mg/0.6 mL Onpro Subcut Device
Gross
$21,180
405810649
$8,684
pegfilgrastim 6 mg/0.6 mL Onpro Subcut Device
Gross
$21,180
405811343
$8,376
efgartigimod alfa 400 mg/20 mL Inj
Gross
$20,429
405811343
$8,376
efgartigimod alfa 400 mg/20 mL Inj
Gross
$20,429
405805913
$8,297
leuprolide 22.5 mg/3 months Inj (IM)
Gross
$20,237
405805913
$8,297
leuprolide 22.5 mg/3 months Inj (IM)
Gross
$20,237
405810840
$7,681
benralizumab 30 mg/mL Inj Syringe
Gross
$18,734
405810840
$7,681
benralizumab 30 mg/mL Inj Syringe
Gross
$18,734
405807997
$7,676
pegfilgrastim 6 mg/0.6 mL Subcut Syringe
Gross
$18,723
405807997
$7,676
pegfilgrastim 6 mg/0.6 mL Subcut Syringe
Gross
$18,723
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 405811353 | sipuleucel-T 250 mL IV Susp | $102,300 | $41,943 | — | — | 9 |
| 405811353 | sipuleucel-T 250 mL IV Susp | $102,300 | $41,943 | — | — | 8 |
| 405810920 | pegloticase 8 mg/mL Inj | $94,485 | $38,739 | — | — | 9 |
| 405810920 | pegloticase 8 mg/mL Inj | $94,485 | $38,739 | — | — | 8 |
| 405810763 | ocrelizumab 300 mg/10 mL Inj Soln | $65,058 | $26,674 | — | — | 9 |
| 405810763 | ocrelizumab 300 mg/10 mL Inj Soln | $65,058 | $26,674 | — | — | 8 |
| 405811243 | polatuzumab vedotin 140 mg Inj | $57,893 | $23,736 | — | — | 9 |
| 405811243 | polatuzumab vedotin 140 mg Inj | $57,893 | $23,736 | — | — | 8 |
| 405811442 | guselkumab 200 mg/20 mL IV Inj | $48,070 | $19,709 | — | — | 9 |
| 405811442 | guselkumab 200 mg/20 mL IV Inj | $48,070 | $19,709 | — | — | 8 |
| 405810353 | leuprolide 45 mg/6 months Inj | $40,474 | $16,594 | — | — | 9 |
| 405810353 | leuprolide 45 mg/6 months Inj | $40,474 | $16,594 | — | — | 8 |
| 405810645 | icatibant 30 mg/3 mL syringe | $36,787 | $15,083 | — | — | 9 |
| 405810645 | icatibant 30 mg/3 mL syringe | $36,787 | $15,083 | — | — | 8 |
| 405811298 | ublituximab-xiiy 150 mg/6 mL Inj | $34,560 | $14,170 | — | — | 9 |
| 405811298 | ublituximab-xiiy 150 mg/6 mL Inj | $34,560 | $14,170 | — | — | 8 |
| 405811316 | risankizumab-rzaa 600 mg/10 mL IV Soln | $32,360 | $13,268 | — | — | 9 |
| 405811316 | risankizumab-rzaa 600 mg/10 mL IV Soln | $32,360 | $13,268 | — | — | 8 |
| 405810690 | lanreotide 120 mg/0.5 mL Subcut Soln syringe | $29,346 | $12,032 | — | — | 9 |
| 405810690 | lanreotide 120 mg/0.5 mL Subcut Soln syringe | $29,346 | $12,032 | — | — | 8 |
| 405803773 | alteplase 100 mg/100 mL (EMERGENT OVERRIDE PE and MI ONLY) IV Inj | $29,042 | $11,907 | — | — | 9 |
| 405810960 | alteplase 100 mg/100 mL (continuous for MI) IV Inj | $29,042 | $11,907 | — | — | 9 |
| 405803773 | alteplase 100 mg/100 mL (EMERGENT OVERRIDE PE and MI ONLY) IV Inj | $29,042 | $11,907 | — | — | 8 |
| 405810960 | alteplase 100 mg/100 mL (continuous for MI) IV Inj | $29,042 | $11,907 | — | — | 8 |
| 405810415 | vedolizumab 300 mg IV Inj | $28,600 | $11,726 | — | — | 9 |
| 405810415 | vedolizumab 300 mg IV Inj | $28,600 | $11,726 | — | — | 8 |
| 405809439 | natalizumab 300 mg/15 mL IV Inj | $27,091 | $11,107 | — | — | 9 |
| 405809439 | natalizumab 300 mg/15 mL IV Inj | $27,091 | $11,107 | — | — | 8 |
| 405807552 | leuprolide 30 mg/4 months Inj | $26,983 | $11,063 | — | — | 9 |
| 405807552 | leuprolide 30 mg/4 months Inj | $26,983 | $11,063 | — | — | 8 |
| 405507171 | IR Fem/Pop Stent + Ather PTAIR FEM/POP STENT + ATHER PTA | $25,321 | $10,382 | — | — | 9 |
| 405507175 | IR Tib/Per Stent + Ather PTAIR TIB/PER STENT PTA + ATHER PTA | $25,321 | $10,382 | — | — | 9 |
| 405507171 | IR Fem/Pop Stent + Ather PTAIR FEM/POP STENT + ATHER PTA | $25,321 | $10,382 | — | — | 8 |
| 405507175 | IR Tib/Per Stent + Ather PTAIR TIB/PER STENT PTA + ATHER PTA | $25,321 | $10,382 | — | — | 8 |
| 405811275 | tenecteplase 50 mg/10 mL Inj | $25,079 | $10,282 | — | — | 9 |
| 405811275 | tenecteplase 50 mg/10 mL Inj | $25,079 | $10,282 | — | — | 8 |
| 405811361 | ravulizumab-cwvz 300 mg/3 mL Inj | $21,556 | $8,838 | — | — | 9 |
| 405811361 | ravulizumab-cwvz 300 mg/3 mL Inj | $21,556 | $8,838 | — | — | 8 |
| 405810930 | eculizumab 300 mg/30 mL IV Soln | $21,526 | $8,826 | — | — | 9 |
| 405810930 | eculizumab 300 mg/30 mL IV Soln | $21,526 | $8,826 | — | — | 8 |
| 405810649 | pegfilgrastim 6 mg/0.6 mL Onpro Subcut Device | $21,180 | $8,684 | — | — | 9 |
| 405810649 | pegfilgrastim 6 mg/0.6 mL Onpro Subcut Device | $21,180 | $8,684 | — | — | 8 |
| 405811343 | efgartigimod alfa 400 mg/20 mL Inj | $20,429 | $8,376 | — | — | 9 |
| 405811343 | efgartigimod alfa 400 mg/20 mL Inj | $20,429 | $8,376 | — | — | 8 |
| 405805913 | leuprolide 22.5 mg/3 months Inj (IM) | $20,237 | $8,297 | — | — | 9 |
| 405805913 | leuprolide 22.5 mg/3 months Inj (IM) | $20,237 | $8,297 | — | — | 8 |
| 405810840 | benralizumab 30 mg/mL Inj Syringe | $18,734 | $7,681 | — | — | 9 |
| 405810840 | benralizumab 30 mg/mL Inj Syringe | $18,734 | $7,681 | — | — | 8 |
| 405807997 | pegfilgrastim 6 mg/0.6 mL Subcut Syringe | $18,723 | $7,676 | — | — | 9 |
| 405807997 | pegfilgrastim 6 mg/0.6 mL Subcut Syringe | $18,723 | $7,676 | — | — | 8 |
Showing top 50 of 26,127 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.